ZNF280B Polyclonal antibody

• 

  WB analysis using 32519-1-AP

  Various lysates were subjected to SDS PAGE followed by western blot with 32519-1-AP (ZNF280B antibody) at dilution of 1:2000 incubated at room temperature for 1.5 hours.

ZNF280B Polyclonal Antibody for WB, ELISA

Cat No. 32519-1-AP

Host / Isotype

Rabbit / IgG

Reactivity

human

Applications

WB, ELISA

Synonyms

Zinc finger protein 632, Zinc finger protein 280B, Zinc finger protein 279, Suppressor of hairy wing homolog 2, SUHW2

---

Tested Applications

• Positive WB detected in: K-562 cells, U2OS cells

Recommended dilution

• Western Blot (WB): WB : 1:1000-1:4000

It is recommended that this reagent should be titrated in each testing system to obtain optimal results.

Sample-dependent, Check data in validation data gallery.

Product Information

32519-1-AP targets ZNF280B in WB, ELISA applications and shows reactivity with human samples.

• Tested Reactivity: human
• Host / Isotype: Rabbit / IgG
• Class: Polyclonal
• Type: Antibody
• Immunogen: ZNF280B fusion protein Ag38544
• Full Name: zinc finger protein 280B
• Calculated Molecular Weight: 62kDa，543aa
• Observed Molecular Weight: 60 kDa
• GenBank Accession Number: NM_080764.3
• Gene Symbol: ZNF280B
• Gene ID (NCBI): 140883
• Conjugate: Unconjugated
• Form: Liquid
• Purification Method: Antigen affinity Purification
• UNIPROT ID: Q86YH2
• Storage Buffer: PBS with 0.02% sodium azide and 50% glycerol, pH 7.3.
• Storage Conditions: Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20^oC storage. 20ul sizes contain 0.1% BSA.

Background Information

ZNF280B belongs to the family of zinc finger proteins, a transcription factor that is mainly involved in the regulation of gene expression. In prostate cancer cells, ZNF280B induces p53 nuclear export, leading to subsequent proteasomal degradation. Therefore, ZNF280B has pro-growth and pro-survival functions in prostate cancer cells. In addition to this, ZNF280B has a promotional role in gastric and lung cancer development, and its potential as a tumor therapeutic target can be explored in the future.